Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
+0.72%
N225
+1.43%
AXJO
-0.43%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
6.33B
Dividend Yield
0.00%
P/E Ratio
-13.81
EPS
-3.04
Revenue
705.14M
Avg. Volume
2.06M

Recently from Cashu

publisher logo
Cashu

Ionis Pharmaceuticals' Partner Biogen Advances SMA Therapy with Promising Phase 1 Results

2 days ago
publisher logo
Cashu

Ionis Pharmaceuticals: Navigating Mixed Analyst Sentiment in RNA-Targeted Therapies

14 days ago
publisher logo
Cashu

Ionis Pharmaceuticals: Balancing Innovation and Challenges in RNA-Targeted Therapies

16 days ago

About

What does IONS do?
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.ionispharma.com
Stocks
Health Care
ions
Ionis Pharmaceuticals
IONS
-0.01 (-0.03%)
39.77
USD
At close at Jun 27, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials